Info

🌱 來自: lymphoma and CLL

hodgkin lymphoma (HL)

(Am J Hematol 2018;93:704; Lancet 2021;398:1518)

Epidemiology and risk factors

• Represents ~12% of lymphomas

• ~8-9K cases annually in US, resulting in ~1300 deaths

• Typically affects younger pts (20s-30s) but can also affect older adults

• ~9,000 cases/y;

• bimodal (15-35 & >50 y)

• ↑ ♂

• EBV in of HL,

  • esp. immunocompromised (eg, HIV)

• pathology of hodgkin lymphoma (HL)

• WHO Histologic Classification of Classical HL

• treatment of hodgkin lymphoma (HL)

Hallmark Study Recently

SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL). Journal of Clinical Oncology. Published 2023. Accessed January 21, 2024. https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.17_suppl.LBA4 ‌

• SWOG S1826